Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma

NCT01498783 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Malignancies
Ependymoma

Interventions

DRUG: 5-fluorouracil

Sponsor

St. Jude Children's Research Hospital